According to a study by Chevalier and colleagues, a single intra-articular injection of anakinra is no more effective than placebo for treating the symptoms of knee osteoarthritis (OA).

Pacira BioSciences PCRX announced that the FDA has cleared its application to market a new Smart Tip for the iovera system designed ... It has been widely used to manage knee pain and is also ...

The iovera system is a FDA-cleared ... It is most commonly used to treat knee pain, but frequently used to manage pain in the hip, shoulder, chest, foot and ankle, and more.

It is most commonly used to treat knee pain, but frequently used to manage ... With the introduction of this new iovera° Smart Tip, Pacira aims to address these gaps and elevate the standard ...

In one study, the majority of the patients suffering from osteoarthritis of the knee experienced pain and system relief beyond 150 days. When stimulation compatible components are used, the iovera° ...

Pacira’s iovera portfolio previously included a three-pronged Smart Tip with 8.5-mm 27-gauge needles for superficial nerves and a 90-mm 20-gauge Smart Tip for deeper nerves. It has been widely used to ...

It is most commonly used to treat knee pain but frequently used to manage pain in the hip ... yet only 2 to 3 million undergo interventional procedures. With the introduction of this new iovera° Smart ...